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The  purpose  of  the  present  study  was  to investigate  the effects  of  phytic  acid (IP6)  on
morphological  and  immunohistochemical  parameters  on  intestinal  explants  exposed  to
deoxynivalenol  (DON)  and  fumonisin  B1 (FB1).  The  jejunal  explants  were  exposed  for  4 h
to different  treatments:  control,  DON  (10  M),  DON  plus  2.5 mM  or 5 mM  IP6,  FB1  (70 M),
and FB1  plus  2.5 mM  or 5 mM  IP6.  Both  mycotoxins  induced  signiﬁcant  intestinal  lesions
and  decreased  villi  height.  The  presence  of  2.5 mM  and  5 mM  IP6  signiﬁcantly  inhibited  the
morphological  changes  caused  by the  mycotoxins.  DON  induced  a signiﬁcant  increase  in
caspase-3  (83%)  and  cyclooxygenase-2  (71.3%)  expression  compared  with  the  control.  The
presence of 5  mM  IP6  induced  a  signiﬁcant  decrease  in caspase-3  (43.7%)  and  Cox-2  (48%)
expression  compared  with  the DON  group.  FB1  induced  a signiﬁcant  increase  in caspase-3
expression  (47%)  compared  to the control,  whereas  IP6  induced  no signiﬁcant  change  in
this expression.  A signiﬁcant  decrease  in  cell  proliferation  was  observed  when  explants
were  exposed  to  5 mM  of  IP6  in  comparison  with  the  DON  and  FB1  groups.  The  present
data  provide  evidence  that  phytic  acid modulates  the  toxic  effects  induced  by DON  and FB1
on intestinal  tissue.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The search for high-quality and healthy food is con-
stantly increasing worldwide, leading to a great interest
in  natural antioxidants, mainly plant extracts and com-
pounds, and their possible health beneﬁts [1]. The inositol
hexaphosphate (IP6, InsP6, phytic acid) is a natural antiox-
idant  widely present in cereals, legumes, nuts, oil seeds,
spores, needles and pollen and corresponds to 1–5% of
∗ Corresponding author at: Universidade Estadual de Londrina, Depar-
tamento de Medicina Veterinária Preventiva, Rodovia Celso Garcia Cid,
Pr  445 Km 380, Campus Universitário Cx. Postal 10.011, CEP 86.057-970,
Londrina, PR, Brazil. Tel.: +55 43 3371 4062.
E-mail address: ana.bracarense@pq.cnpq.br (A.P.F.R.L. Bracarense).
http://dx.doi.org/10.1016/j.toxrep.2014.05.001
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. Th
(http://creativecommons.org/licenses/by-nc-nd/3.0/).the weight of the cereals [2,3]. Several studies in human
and animal models have demonstrated the preventive and
therapeutic effects of IP6 in different diseases, including
inhibition of platelet aggregation [4], reduction of serum
lipids  [5], protective effects in inﬂammatory bowel dis-
ease  [6] and neurodegenerative diseases [7], prevention of
cardiovascular diseases [8], prevention of kidney stone for-
mation  [9] and inhibition of cancer development [10–18].
The  protective effect of IP6 has been related to its antiox-
idant potential in inhibiting radical oxygen species (ROS)
production [6,19].
The  intestine is a complex organ with several cell types,
functions, serves as the primary barrier against the inges-
tion  of chemicals, antigens, natural toxins, contaminated
food [20,21]. Mycotoxins, such as deoxynivalenol (DON),
fumonisin B1 (FB1), induce toxic, immunotoxic effects
is is an open access article under the CC BY-NC-ND license
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n the intestine of pigs [22]. Mycotoxins are the most
ommon contaminants of cereal grains found worldwide
23], are considered a risk factor to human, animal health
24].
The  toxic effects of fusariotoxins have been reported
n humans, pigs, experimental animals and in vitro mod-
ls  [22,25–27]. Upon acute exposure to high doses of DON,
nimals  exhibit diarrhea, vomiting, leukocytosis and hem-
rrhage  [28], whereas chronic exposure induces anorexia,
educed weight gain and nutritional efﬁciency, and changes
o  the neuroendocrine and immune systems [29]. At the
olecular level, DON acts to inhibit protein synthesis
y binding to the 28S ribosomal RNA peptidyltransferase
ite, inducing the phosphorylation of mitogen-activated
rotein kinases (MAPKs), promoting apoptosis, and induc-
ng  changes in cytokine gene expression [30,31] and
 decrease in the expression of cell adhesion proteins
22,32,33].
Exposure to cereals contaminated with FB1 causes pul-
onary edema in pigs [34], leukoencephalomalacia in
orses  [35], liver and kidney cancer in rats [36,37] and
sophageal cancer and neural tube defects in humans
38,39]. At the cellular level, FB1 inhibits ceramide syn-
hase,  blocking the synthesis of sphingolipids, a class of
embrane lipids that plays an important role in cell
ignaling transduction pathways and cell growth, differ-
ntiation and death [40,41].
In a previous study, we demonstrated that IP6 modu-
ates the toxic effects induced by DON exposition on IPEC
ells  [42]. In this study, we are interested in evaluating
he effects of phytic acid on an ex vivo model exposed to
ON  and FB1, the most common fusariotoxins that con-
aminate cereals. Furthermore, we focus on the search
or  compounds that can inhibit or inactivate the action
f  these mycotoxins. The beneﬁcial effects of IP6 have
een demonstrated in several diseases; however, there
re  few reports on IP6 action during mycotoxin exposure
42,43]. Our hypothesis is that the antioxidant proper-
ies of IP6 contribute to reduce the ribotoxic stress and
ipid  peroxidation caused by DON and FB1, respectively.
he choice of the swine as the experimental model was
ased  on the physiological and morphological similarities
ith the human gastrointestinal tract as well as similarities
n  the absorption of IP6 [44]. The explant culture tech-
ique used in this experiment permits the evaluation of
issue  morphology, maintaining the complex patterns of
ifferentiation observed in vivo and permitting the use of
ewer  experimental animals [21]. The aim of this study
as  to investigate the effect of IP6 on jejunal explants
xposed to DON and FB1, focusing on intestinal morphol-
gy, cell proliferation and apoptosis. The expressions of a
ell  junction protein and cyclooxygenase-2 were also ana-
yzed.
.  Materials and methods
.1.  AnimalsSix 24-day-old crossbred (Landrace × Large
hite × Duroc) piglets (7.9 kg ± 0.72) were used in
he present study. All animal experimentation proceduresports 1 (2014) 284–292 285
were  performed in accordance with the ethics commit-
tee on the use of animals (CEUA/UEL/Brazil-process n◦
8022.2012.40).
2.2. Phytic acid
Phytic  acid (inositol hexaphosphoric acid) dodeca-
sodium salt from rice (MW:  1080) was  purchased from
Sigma–Aldrich (St. Louis, MO,  USA). The salt was  dissolved
in  distilled water and the pH was  adjusted to 7.2 before
the  solution was  passed through a membrane ﬁlter. The
resultant solution was stored at −20 ◦C before dilution in
explant culture media. The IP6 concentrations used in this
study  (2.5 mM and 5 mM)  were chosen based in a previous
experiment with swine jejunal explants where these doses
improved the jejunal morphology compared to lower doses
[44].
2.3.  DON and FB1 mycotoxins
The  puriﬁed DON (MW:  296.32) and FB1 (MW:  721.83)
mycotoxins were purchased from Sigma–Aldrich (St. Louis,
MO,  USA) and the Cayman Chemical Company (MI, USA),
respectively. The mycotoxins were dissolved in ultrapure
water at ﬁnal dilution of 10 M for DON and 70 M for
FB1 and stored at −20 ◦C. The concentrations of mycotoxins
used were equivalent to 3 mg  kg−1 feed and 50.5 mg kg−1
of feed for DON and FB1, respectively.
The doses used in this experiment were based in previ-
ous  experiments [46,47] that have shown toxic effects with
these  concentrations in the explant model.
2.4. Jejunal explants technique
The  jejunum was  chosen because previous studies have
identiﬁed this region as a target of the toxic action of
DON  and FB1 [22]. The piglets were euthanized by the
administration of acepromazine 1% (0.1 mL/10 Kg) IM,
sodium pentobarbital (40 mg/kg) IV and, subsequently,
KCl 15% solution IV. The jejunum was  rapidly excised,
and samples 5 cm in length were collected, washed with
buffer  solution and opened longitudinally. The explants
were collected using a punch 8 mm in diameter. From
each animal six explants (replicates) were collected for
each  treatment. The total number of explants from each
pig  was 42. The explants collected were laid in six well
plates (three explants/well) with 3 mL  of the following
treatments: control (A, B and C) – only culture media
(DMEM – Dulbecco’s modiﬁed Eagle’s medium (Gibco) plus
penicillin/streptomycin (1.25 L/mL – Gibco), gentamicin
(10 L/mL – Novafarma), fetal bovine serum (100 L/mL –
Invitrogen) and l-glutamine (0.4 L/mL – Sigma–Aldrich);
culture media with IP6 2.5 mM (D and E); and culture media
with  IP6 5 mM  (F and G). The explants were incubated at
37 ◦C under orbital shaking. After one hour, DON (10 M)
was  added in the B, D and F treatments, and FB1 (70 M)
in  the C, E and G treatments. The explants were returned
to incubation for three more hours. The total time of incu-
bation  (4 h) was chosen to encompass the times previously
used in an experiment with explants of swine jejunum [48].
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Table  1
Histological criteria score used to establish the jejunal lesional score*
Type of lesion Severity score Maximal total score
Villi atrophy 0–2 22
Villi  fusion 0–2
Interstitial  edema 0–2
Lymphatic  vessel dilation 0–2
Loss  of apical enterocytes 0–2
Cell  vacuolation 0–2
Necrotic debris 0–2
Microvilli  Homogeneity 0–2
Enterocytes  morphology# 0–3
Number  of villi• 0–3
* The jejunal score of each treatment was obtained by the sum of each
lesion score. The severity score was determined as: 0-diffuse; 1-local; 2-
absent.
# Columnar epithelium (3); cuboid epithelium (2); ﬂattened epithelium
(1); no epithelium (0).
• >25 villi/explant (3); 15–25 villi (2); <15 villi (1) and no villi (0).
2.5. Histological assessment
After  the incubation period, the explants were ﬁxed in
10%  neutral buffered formalin, dehydrated in alcohols and
embedded  in parafﬁn. Sections of 5 m were stained with
hematoxylin-eosin (HE) for histopathological evaluation.
An  intestinal histological score previously described [47]
was  used to compare the histological changes between the
treatments. The frequency and severity of each lesion was
evaluated on a scale in which the maximal total score was
22  points (Table 1). The villi height was measured randomly
on  10 villi using an image analysis system (Motic Image
Plus,  Motic Instruments, Richmond, Canada). Sections of
the  jejunum were submitted to alcian blue staining to eval-
uate  goblet cell density. Positively stained goblet cells were
counted  randomly in 10 villi per explant at 400× magniﬁ-
cation.
2.6. Immunohistochemical assessment
The evaluation of cell junction expression, cell prolif-
eration, apoptosis and cyclooxygenase-2 expression were
performed using antibodies against E-cadherin (anti-
4A2C7, 1:50, Zymed), Ki-67 (anti-7B11, 1:50 dilution,
Zymed), cleaved caspase-3 (Ccasp-3) (anti-Asp 175, 1:200
dilution,  Cell Signaling Technology, Inc.) and Cox-2 (anti-
CX-294, 1:100 dilution, Dako), respectively. An anti-p53
antibody (anti-BP53.12, 1:50 dilution, Zymed) was used to
evaluate  the expression of p53. Samples of jejunum were
analyzed on formalin-ﬁxed and parafﬁn-embedded sec-
tions.  Tissue sections were deparafﬁnized with xylene and
dehydrated through a graded ethanol series. The positive
and  negative controls were used according to the manufac-
turer’s instructions.
Heat-mediated antigen retrieval was performed by
heating the sections immersed in EDTA buffer, pH 9.0,
in  a microwave oven (750 W)  for 10 min  for E-cadherin,
Ki-67, Cox-2, and p53 staining and for 17 min  for Ccasp-
3  staining. Endogenous peroxidase activity was  blocked
by  incubation in a methanol–H2O2 (100: 50 mL)  solution,
whereas for Ccasp-3 and Cox-2, a blocker protein (Dako)
was  also used for 30 min. The sections were incubatedports 1 (2014) 284–292
overnight at 4 ◦C with the primary antibody. The polymer
secondary antibody (Nichirei Biosciences, Tokyo, Japan)
was  applied for 30 min, followed by the addition of a chro-
mogen  (3,3-diaminobenzidine). Finally, the tissue sections
were  counterstained with hematoxylin and mounted on
coverslips  using a permanent mounting medium.
The positive immunoexpression of Ccasp-3, p53 and
Ki-67 was estimated by counting strongly positive immu-
nostaining of the cytoplasm (Ccasp-3) and nucleus (p53,
Ki-67)  in ﬁve random ﬁelds in the crypt region/explant
at 400× magniﬁcation. The expression of E-cadherin was
estimated by the evaluation of ﬁve ﬁelds at 200× mag-
niﬁcation. The staining was considered positive when
homogeneous and strong basolateral membrane staining
of  the enterocytes was observed. The expression of Cox-2
was  estimated by evaluating ﬁve ﬁelds in the crypt region at
200×  magniﬁcation. Fields were considered positive when
75%  or more of the cells were immunostained.
2.7. Statistical analysis
The  experimental design used in the present study was
entirely randomized with six replicates for each treatment
(each explant represent one replicate). The means of the
lesional  score, intestinal morphometry, number of goblet
cells,  positive immunostaining for Ki-67, p53, and Ccasp-
3  and the number of positive ﬁelds for E-cadherin and
Cox-2 were used for statistical analysis. The data are pre-
sented  as the means with their standard errors and were
analyzed using the free software Action 2.3 (Campinas, SP,
Brazil).  One-way analysis of variance (ANOVA) followed by
a  multiple comparison procedure (Tukey test) was used
for  statistical analysis. Fisher’s test was used to compare
the  results of E-cadherin and Cox-2 expression. P values of
≤0.05  were considered signiﬁcant.
3. Results
3.1. Effect of IP6 on the histology and morphometry of
jejunal explants exposed to DON and FB1mycotoxins
After 3 h of incubation with DON or FB1, the explants
exhibited moderate to severe jejunal lesions. The main
histological changes observed included multifocal to dif-
fuse  atrophy and villi fusion, the lack of apical epithelium,
necrotic debris, cell vacuolation and the ﬂattening of
enterocytes (Fig. 1). Histological scores decreased signif-
icantly in the explants exposed to DON (31.4%) and FB1
(23%)  compared with the control group. On the other
hand, when the explants were pre-treated with 2.5 mM
and  5 mM of IP6, the histological scores exhibited a signiﬁ-
cant  increase (p ≤ 0.05) compared with explants exposed to
mycotoxins  alone (Fig. 1). Explants submitted to 2.5 mM IP6
exhibited  an increase of 30.8% and 23.8% after DON and FB1
treatment, respectively, whereas 5 mM of IP6 induced an
increase  of 38.3% and 24.6% in histological score in explants
exposed to DON and FB1, respectively.Explants exposed to DON exhibited a signiﬁcant
decrease (50%) in villi height compared with the control.
However, explants treated with 2.5 mM or 5 mM of IP6
exhibited a signiﬁcant increase in villi height (70.2% and
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Fig. 1. The effects of IP6 on the histological morphology of jejunal explants exposed to DON and FB1. DON(1)-DON alone; DON(2)-DON plus 2.5 mMIP6;
DON(3)-DON  plus 5 mM IP6; FB1(1)-FB1 alone; FB1(2)-FB1 plus 2.5 mM IP6; FB1(3)-FB1 plus 5 mM IP6. (A) Effect of IP6 on the lesional score of explants
exposed  to DON and FB1 (AU-Arbitrary Units). (B) Effect of IP6 on the villi height of explants exposed to DON and FB1 (m).  Mean values with unlike
letters  were signiﬁcantly different (p ≤ 0.05). (C) Control treatment with normal morphology. HE, bar 100 m. (D) DON alone; villi atrophy and loss of the
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1.8%, respectively) compared with explants exposed to
ON  (Fig. 1). Explants incubated with FB1 exhibited a
igniﬁcant decrease in villi height (35%) compared with
he  control group, whereas pre-treatment with 2.5 mM  or
 mM of IP6 promoted an increase of 54.5% (p ≤ 0.05) and
5.5%  (p ≥ 0.05) in villi height, respectively.
Goblet  cell density was estimated by counting the num-
er  of goblet cells per villi. The mean number of goblet cells
as  4, 3.4 and 3.8 for the control, DON and FB1 explants,
espectively. Treatments with 2.5 and 5 mM of IP6 induced
o  signiﬁcant changes in goblet cell density compared with
xplants  treated with DON and FB1 alone (data not shown).
.2.  Effect of IP6 on cell proliferation and apoptosis in
ejunal explants exposed to DON and FB1 mycotoxins
Cell proliferation and apoptosis were assessed using an
mmunohistochemical assay to detect Ki-67 and cleaved
aspase-3, respectively. Explants exposed to DON and
B1  exhibited no signiﬁcant change in cell proliferation
ompared with the control group. However, explants pre-
iously  treated with 5 mM of IP6 exhibited a signiﬁcant
ecrease (28.6%) in Ki-67 expression compared with the
xplants  exposed to DON (Fig. 2). Moreover, IP6 treatment
lso  induced a signiﬁcant decrease in cell proliferation
ompared with explants exposed to FB1 alone (22% and
0%  for 2.5 and 5 mM of IP6, respectively).0 m. (F) DON plus 5 mM IP6 showing histological aspects similar to the
f the apical enterocytes. HE, bar 50 m. (H) FB1 plus 5 mM IP6 showing
A signiﬁcant increase in caspase-3 expression was
observed in explants exposed to DON (83%) and FB1
(47%) compared with the control group. Nonetheless, when
explants  were exposed to DON plus 5 mM IP6, a sig-
niﬁcant decrease (43.7%) in cell apoptosis was observed
compared with the DON group. Explants exposed to 2.5 mM
IP6  plus DON exhibited no changes in caspase-3 expres-
sion  compared with the DON group. No signiﬁcant change
in  caspase-3 expression was observed when the explants
were treated with IP6 plus FB1 compared with the FB1
group (Fig. 2).
The  expression of p53 was  assessed to evaluate the
relationship of p53 with apoptosis induction. No immu-
nostaining was observed in control explants or explants
exposed to mycotoxins alone or with IP6 treatments.
3.3. Effect of IP6 on the expression of junction proteins
and cyclooxygenase-2 on jejunal explants exposed to
DON  and FB1 mycotoxins
Oxidative  stress was evaluated by the immunoexpres-
sion of Cox-2. Explants exposed to DON alone exhibited a
signiﬁcant  increase (71.3%) in Cox-2 expression compared
with  the control. However, in explants treated with IP6
(5  mM)  plus DON, we observed a signiﬁcant decrease (48%)
in  Cox-2 expression in comparison with the DON group.
Exposure to FB1 alone or in addition to IP6 induced no
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Fig. 2. The effects of IP6 on the cell proliferation (ki-67) and apoptosis (Ccasp-3) on jejunal explants exposed to DON and FB1. DON(1)-DON alone; DON(2)-
DON  plus 2.5 mMIP6; DON(3)-DON plus 5 mM IP6; FB1(1)-FB1 alone; FB1(2)-FB1 plus 2.5 mM IP6; FB1(3)-FB1 plus 5 mM IP6. (A) Mean number of Ki-67
immunostained  cells per ﬁeld on explants exposed to the different treatments. (B) Mean number of Ccasp-3 immunostained cells per ﬁeld on explants
 signiﬁca
 immun
-3 immuexposed  to the different treatments. Mean values with unlike letters were
immunostaining in crypt cells. (D) DON alone; strong and diffuse Ccasp-3
immunostaining  in crypt cells. (F) DON plus 5 mM IP6; reduction in Ccasp
signiﬁcant change in Cox-2 immunoexpression in the
explants (Fig. 3).
The  expression of E-cadherin was assessed to evaluate
adherens junction integrity. Explants exposed to DON and
FB1  alone or with the addition of IP6 exhibited no signiﬁ-
cant  changes in E-cadherin expression (Fig. 3).
4. Discussion
Phytic acid is a potent natural antioxidant component
of cereal diets that can modulate inﬂammatory and car-
cinogenic diseases [19,48]. Most studies on phytic acid
thus  far have focused on the antineoplastic effects of IP6,
whereas the effects on inﬂammation are unknown, and the
mechanisms of anti-inﬂammatory action remain poorly
understood.
The  effects of IP6 on inﬂammatory diseases have been
associated with the inhibition of reactive oxygen species
(ROS) production, the increase in TGF- (transforming
growth factor-beta) gene expression, the decrease in TNF-
  (tumor necrosis factor-alpha) transcription and the
modulation of proinﬂammatory cytokine secretion in the
intestinal  epithelium [49,50]. Previous studies have indi-
cated  that the intestinal tissue is a target for deoxynivalenol
[22] and fumonisin B1 [51]. Efforts to alleviate the toxicntly different (p ≤ 0.05). (C) Control treatment; mild Ccasp-3 cytoplasmic
ostaining in crypt cells. (E) FB1 alone; moderate to accentuated Ccasp-3
nostaining in crypt cells. (C)–(F) Immunoperoxidase method, bar 25 m.
effects  of mycotoxins have been an area of research inter-
est  for our group [52]. In the present study, we present
evidence that phytic acid promotes a protective effect on
jejunal  explants exposed to Fusarium mycotoxins.
The main histological changes observed in jejunal
explants exposed to DON and FB1 alone included atrophy
and  fusion of the villi, loss of apical enterocytes, necrotic
debris and changes in enterocytes morphology. Similar
lesions were observed in previous studies with in vivo and
ex  vivo exposure to DON and FB1 [22,47]. In this study,
we  observed a protective effect of IP6. This effect could be
evaluated by an increase in the histological score and the
villi  height in explants exposed to IP6. In a previous exper-
iment,  we observed that doses of 2.5 mM and 5 mM IP6
improved the intestinal morphology and villi height of jeju-
nal  explants submitted to hypoxia [45]. IP6 likely acts on
intestinal  morphology by inhibiting the ribotoxic stress and
lipid  peroxidation caused by DON and FB1, respectively,
through its antioxidant action. Moreover, the increase in
intracellular IP6 may  promote cellular differentiation and
morphology preservation through the modulation of apo-
ptosis  and proliferation signal transduction, as observed
in  colon cancer studies [10,11]. In the present study, no
signiﬁcant change in goblet cell density was observed in
explants  submitted to the different treatments. In in vivo
E.O. da Silva et al. / Toxicology Reports 1 (2014) 284–292 289
Fig. 3. The effects of IP6 on cyclooxygenase and E-cadherin expression in jejunal explants exposed to DON and FB1. DON(1)-DON alone; DON(2)-DON plus
2.5  mMIP6; DON(3)-DON plus 5 mM IP6; FB1(1)-FB1 alone; FB1(2)-FB1 plus 2.5 mM IP6; FB1(3)-FB1 plus 5 mM IP6. (A) Effect of IP6 on Cox-2 expression
in  explants exposed to the different treatments. (B) Effect of IP6 on E-cadherin expression in explants exposed to the different treatments. Percentage
v l treatm
a  cytopla
2
s
c
i
e
i
r
r
c
t
a
t
p
a
m
d
g
aalues  with unlike letters were signiﬁcantly different (p ≤ 0.05). (C) Contro
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5  m.
tudies, pigs fed diets with FB1 and DON exhibited signiﬁ-
ant  changes in goblet cells density [22,53]. The difference
n  these results is likely related to the short period of
xposure to mycotoxins (3 h) in this ex vivo model. The
nteractions between IP6 and intestinal mucin production
emain to be investigated.
Studies  in vitro and in vivo exhibited contradictory
esults with respect to the proliferation of intestinal
ells after DON [22,33,54] and FB1 [22,55] exposure. In
his  experiment, the explants exposed to DON and FB1
lone  exhibited proliferative cell indexes similar to con-
rol  explants. Interestingly, the combination of 5 mM IP6
lus  the mycotoxins promoted a signiﬁcant decrease of 28%
nd  30% in cell proliferation compared with DON and FB1
ycotoxin treatment alone, respectively. Phytic acid can
ecrease  cell proliferation by binding to the insulin-like
rowth factor II (IGF-II) receptor, decreasing DNA synthesis
nd  proliferating cell nuclear antigen (PCNA) and blockingent; mild cytoplasmic immunostaining for Cox-2. (D) DON alone; strong
smic immunostaining for Cox-2. (C)–(E) Immunoperoxidase method, bar
ERK  1/2 signaling to arrest the cells in the G1 phase of the
cell  proliferation cycle [16]. However, no data concerning
the interaction between IP6 and Ki-67 expression in cell
proliferation are available. We  hypothesized that similar
to  the action reported on PCNA, IP6 inhibits the expression
of  Ki-67, leading to cell quiescence.
In the present study, cell apoptosis was evaluated by the
positive immunoexpression of Ccasp-3. In the crypt region,
we  observed an increase of 83% and 47% in caspase-3
expression in explants exposed to DON and FB1, respec-
tively. Such changes reﬂected on the decrease in villi height
in  explants exposed to DON and FB1. It has been established
that DON activates p38 MAPKs through a ribotoxic stress
response and the generation of reactive oxygen species
(ROS), inducing cell apoptosis [31,46,56]. In this apoptotic
pathway, Ccasp-3 is activated, and mutation of the p53
gene  may  also occur [31]. The mechanisms for apopto-
sis  induction by FB1 are unclear but likely involve the
ology Re
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disruption of many regulatory cell pathways, including the
inhibition  of protein kinase C and the activation of MAPKs
and  Ccasp-3 due the intracellular accumulation of sphin-
golipids and consequent lipid peroxidation [57,58]. In an
in  vitro study with cancer cells, IP6 decreased the activated
levels of ERK1/2, JNK1/2 and p38 and induced apoptosis
together with a decrease in cell proliferation [12]. However,
phytic acid has the ability to modulate apoptosis through
prevention or induction to protect the cells and prevent
diseases [19]. In this experiment, 5 mM IP6 was able to sig-
niﬁcantly  reduce the cell apoptosis induced by DON. We
hypothesize that IP6 modulated the decrease in cell apo-
ptosis  by inhibiting the activation of MAPKs induced by
the  oxidative stress caused by mycotoxins. We  observed
no  signiﬁcant p53 expression in the explants exposed to
DON  and FB1. It is likely that in this experiment, the short
exposure time, even at high doses of mycotoxin, was  not
sufﬁcient to induce apoptosis linked to activation of the
p53  gene. Taken together, these results suggest that DON
and  FB1 induce apoptosis via the caspase-3 pathway.
In addition to triggering the activation of MAPKs, both
DON  [31,32,54] and FB1 [22,59,60] can decrease cellular
adhesion and transepithelial electrical resistance (TEER)
as  well as increase Cox-2 expression, mainly by upre-
gulation of TNF-. Furthermore, the decrease of cellular
adhesion and the upregulation of Cox-2 expression have
been  related to ROS production and MAPK activation
[61–63]. Changes in cell junction proteins were described
in  explants exposed to DON and FB1 [47]. In the present
study, no signiﬁcant changes in E-cadherin expression
were observed in any of the treatments. However, when the
explants  were exposed to 5 mM IP6, the E-cadherin expres-
sion  improved 28% and 9% compared with the DON and
FB1  groups, respectively. It is likely that, the short period
of  incubation with the mycotoxins (3 h) was insufﬁcient to
induce  a signiﬁcant change in the E-cadherin expression.
We  believe that longer periods of IP6 exposure could confer
higher  protection against the injuries caused by mycotox-
ins  on cell adhesion proteins.
The  expression of Cox-2 has increased 71% in explants
exposed to DON compared with the control, whereas the
incubation with 5 mM IP6 plus DON induced a decrease of
48%.  Similar effects were observed in explants incubated
with FB1 and IP6 (5 mM)  plus FB1, although the differ-
ences were not signiﬁcant. There are few reports of the
effects  of DON and FB1 on Cox-2 expression [60,64]. The
decrease  of Cox-2 expression and TNF- transcription has
been  reported in in vivo [65] and in vitro [49,66] associated
to  IP6 exposure in colon inﬂammatory disease and can-
cer.  Similarly, we observed a signiﬁcant reduction in Cox-2
expression when we compared explants exposed to DON
with  explants treated with IP6. It is well established that
DON  induces the direct production of ROS by a ribotoxic
stress pathway [31,56]. The production of ROS leads to the
expression  of Cox-2, an enzyme that plays an important
role in inﬂammatory reactions [67]. Phytic acid binds to the
coordination sites for iron, preventing the redox activation
necessary to catalyze OH formation by a Fenton reaction
[48]. Therefore, we hypothesize that the decrease in Cox-2
expression observed in this study was associated with the
ability  of IP6 to inhibit ROS production. Fumonisin induced
[
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no  signiﬁcant changes in Cox-2 expression. ROS produc-
tion  induced by FB1 occurs indirectly via the intracellular
accumulation of sphingolipids [57,58]. We  believe that the
short  period of incubation with the FB1 mycotoxin was not
sufﬁcient  to promote an accumulation of sphingolipids that
induced  a signiﬁcant increase in the Cox-2 expression.
In conclusion, the present study demonstrated that
phytic acid alleviates the toxic effects induced by DON
and  FB1 on intestinal tissue. The protective effects were
demonstrated by immunohistological and morphometri-
cal assays. Ingestion of phytic acid could contribute to the
maintenance of intestinal homeostasis, the absorption of
nutrients  and the defense against toxic agents, however
further studies are necessary to understand the mechanism
of  action of this effect in mycotoxin contamination.
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